Search results
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why theStock Is a Smart Buy
Motley Fool via Yahoo Finance· 4 days agoThe stock is an excellent investment for investors looking for a stable, but growing, business....
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews.com
ETF DAILY NEWS· 6 days agoBarclays lifted their target price on Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an “overweight” rating in a report ...
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
Zacks· 3 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both ...
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Vertex Pharmaceuticals...
Benzinga· 1 day agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals . Looking at options history ...
Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Compre
Guru Focus· 2 days agoWith an Earnings Per Share (EPS) of 15.41, the question arises: is Vertex Pharmaceuticals currently overvalued? This analysis aims to explore the intrinsic ...
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Investor's Business Daily· 4 hours agoThe biotech company showed 68% earnings growth last quarter. Sales gains came in at 21%. Halozyme...
Vertex Stock Hit All-Time High, Paused, Rising Again
Investor's Business Daily· 2 days agoHighly rated Vertex Pharmaceuticals (VRTX) continues to trade near its all-time high. The upgraded Relative Strength Rating shows that Vertex stock ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 1 day agoIs CRISPR stock a buy? CRISPR remains on track to start clinical trials for CTX112, a gene-editing...
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 10 hours agoCasgevy, another gene-editing treatment for SCD and TDT, earned approval recently. The team of Vertex Pharmaceuticals and CRISPR Therapeutics developed...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 4 days agoInvestors with cash to spare may also want to start or add to a position in this beauty stock....
